This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. shed 9.8% to $2.02 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.1% to 43,461.21 and the NASDAQ Composite Index falling 1.2% to 19,286.92.
Inovio Pharmaceuticals Inc. closed 86.3% below its 52-week high of $14.75, which the company achieved on April 1st.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson rose 0.9% to $163.74, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 1.33% to $26.65.
Trading volume totaled 835,891, compared to the 50-day average of 1.2 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 24, 2025 16:33 ET (21:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.